Back to Results
First PageMeta Content
Pharmaceutical industry / Technology / New Enterprise Associates / AstraZeneca / MedImmune


FOR IMMEDIATE RELEASE Zyngenia, Inc. Raises $15 Million in Series A Extension Financing - Next-Generation Biotherapeutics Company Will Use Funds to Rapidly Advance Zybody™ Pipeline Gaithersburg, Maryland – September
Add to Reading List

Document Date: 2013-06-10 17:55:54

Open Document

File Size: 140,12 KB

Share Result on Facebook

City

Washington / D.C. / Shanghai / Beijing / Menlo Park / Gaithersburg / Mumbai / Bangalore / /

Company

New Enterprise Associates New Enterprise Associates Inc. / Series A Extension Financing - Next-Generation Biotherapeutics Company Will Use Funds / New Enterprise Associates / Zyngenia Inc. / New Enterprise Associates (India) Pvt. Ltd. / New Enterprise Associates (Beijing) Ltd. / /

Country

United States / China / India / /

Currency

USD / /

Event

Funding / /

Facility

Zyngenia’s pipeline / Rapidly Advance Zybody™ Pipeline / /

IndustryTerm

venture capital / therapies for various cancers / information technology / transformational businesses / venture capital firms / manufacturing / healthcare / energy technology / therapeutics for various cancers / /

MedicalCondition

cancers / autoimmune disorders / autoimmune diseases / /

MedicalTreatment

biologic therapies / /

Person

Peter Kiener / David M. Mott / /

Position

President & Chief Executive Officer / Chairman of the Board / /

ProvinceOrState

Maryland / Montgomery County / California / /

Technology

information technology / antibodies / /

URL

www.zyngenia.com / www.nea.com / /

SocialTag